NCT05236309View on ClinicalTrials.gov

Investigation on the Epidemic Prevention Effect of Using Chinese Medicine During the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Outbreak.

CompletedOBSERVATIONAL

Enrollment

2,000

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

July 31, 2021

Study Completion Date

November 18, 2021

Conditions

COVID-19 Pandemic

Interventions

DRUG

Jing-Guan-Fang(JGF) : Chinese herbal decoction

Use 100ml JGF decoction per day as a preventive measure for patients with COVID-19.

Trial Locations (1)

886

Taipei City Hospital, Taipei

All Listed Sponsors

lead

Taipei City Hospital

OTHER_GOV

NCT05236309 - Investigation on the Epidemic Prevention Effect of Using Chinese Medicine During the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Outbreak. | Biotech Hunter | Biotech Hunter